This report contains market size and forecasts of B Cell Maturation Antigen Targeted Therapy in Global, including the following market information:
Global B Cell Maturation Antigen Targeted Therapy Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global B Cell Maturation Antigen Targeted Therapy market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Antibody-Drug Conjugates Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of B Cell Maturation Antigen Targeted Therapy include GlaxoSmithKline, Johnson & Johnson, Amgen, Seagen, AbbVie, Novartis, BioTherapeutics, Celgene and Bluebird Bio, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the B Cell Maturation Antigen Targeted Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global B Cell Maturation Antigen Targeted Therapy Market, by Treatment Method, 2018-2023, 2023-2030 ($ millions)
Global B Cell Maturation Antigen Targeted Therapy Market Segment Percentages, by Treatment Method, 2022 (%)
Antibody-Drug Conjugates
CAR-T Cells and Bispecific T Cell Engagers
Global B Cell Maturation Antigen Targeted Therapy Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global B Cell Maturation Antigen Targeted Therapy Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global B Cell Maturation Antigen Targeted Therapy Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global B Cell Maturation Antigen Targeted Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies B Cell Maturation Antigen Targeted Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies B Cell Maturation Antigen Targeted Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Johnson & Johnson
Amgen
Seagen
AbbVie
Novartis
BioTherapeutics
Celgene
Bluebird Bio
Bristol Mayer Squibb
Carsgen Therapeutics
Juno Therapeutics
Cogent Bioscience
CRISPR Therapeutics
Allogene Therapeutics
Harpoon Therapeutics
Poseida Therapeutics
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 B Cell Maturation Antigen Targeted Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Treatment Method
1.2.2 Market by Application
1.3 Global B Cell Maturation Antigen Targeted Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global B Cell Maturation Antigen Targeted Therapy Overall Market Size
2.1 Global B Cell Maturation Antigen Targeted Therapy Market Size: 2022 VS 2030
2.2 Global B Cell Maturation Antigen Targeted Therapy Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top B Cell Maturation Antigen Targeted Therapy Players in Global Market
3.2 Top Global B Cell Maturation Antigen Targeted Therapy Companies Ranked by Revenue
3.3 Global B Cell Maturation Antigen Targeted Therapy Revenue by Companies
3.4 Top 3 and Top 5 B Cell Maturation Antigen Targeted Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies B Cell Maturation Antigen Targeted Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 B Cell Maturation Antigen Targeted Therapy Players in Global Market
3.6.1 List of Global Tier 1 B Cell Maturation Antigen Targeted Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 B Cell Maturation Antigen Targeted Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Treatment Method - Global B Cell Maturation Antigen Targeted Therapy Market Size Markets, 2022 & 2030
4.1.2 Antibody-Drug Conjugates
4.1.3 CAR-T Cells and Bispecific T Cell Engagers
4.2 By Treatment Method - Global B Cell Maturation Antigen Targeted Therapy Revenue & Forecasts
4.2.1 By Treatment Method - Global B Cell Maturation Antigen Targeted Therapy Revenue, 2018-2023
4.2.2 By Treatment Method - Global B Cell Maturation Antigen Targeted Therapy Revenue, 2023-2030
4.2.3 By Treatment Method - Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global B Cell Maturation Antigen Targeted Therapy Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global B Cell Maturation Antigen Targeted Therapy Revenue & Forecasts
5.2.1 By Application - Global B Cell Maturation Antigen Targeted Therapy Revenue, 2018-2023
5.2.2 By Application - Global B Cell Maturation Antigen Targeted Therapy Revenue, 2023-2030
5.2.3 By Application - Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global B Cell Maturation Antigen Targeted Therapy Market Size, 2022 & 2030
6.2 By Region - Global B Cell Maturation Antigen Targeted Therapy Revenue & Forecasts
6.2.1 By Region - Global B Cell Maturation Antigen Targeted Therapy Revenue, 2018-2023
6.2.2 By Region - Global B Cell Maturation Antigen Targeted Therapy Revenue, 2023-2030
6.2.3 By Region - Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America B Cell Maturation Antigen Targeted Therapy Revenue, 2018-2030
6.3.2 US B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2030
6.3.3 Canada B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2030
6.3.4 Mexico B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe B Cell Maturation Antigen Targeted Therapy Revenue, 2018-2030
6.4.2 Germany B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2030
6.4.3 France B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2030
6.4.4 U.K. B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2030
6.4.5 Italy B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2030
6.4.6 Russia B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2030
6.4.7 Nordic Countries B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2030
6.4.8 Benelux B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia B Cell Maturation Antigen Targeted Therapy Revenue, 2018-2030
6.5.2 China B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2030
6.5.3 Japan B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2030
6.5.4 South Korea B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2030
6.5.5 Southeast Asia B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2030
6.5.6 India B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America B Cell Maturation Antigen Targeted Therapy Revenue, 2018-2030
6.6.2 Brazil B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2030
6.6.3 Argentina B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa B Cell Maturation Antigen Targeted Therapy Revenue, 2018-2030
6.7.2 Turkey B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2030
6.7.3 Israel B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2030
6.7.4 Saudi Arabia B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2030
6.7.5 UAE B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2030
7 Players Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Corporate Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.1.4 GlaxoSmithKline B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.1.5 GlaxoSmithKline Key News
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Corporate Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.2.4 Johnson & Johnson B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.2.5 Johnson & Johnson Key News
7.3 Amgen
7.3.1 Amgen Corporate Summary
7.3.2 Amgen Business Overview
7.3.3 Amgen B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.3.4 Amgen B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.3.5 Amgen Key News
7.4 Seagen
7.4.1 Seagen Corporate Summary
7.4.2 Seagen Business Overview
7.4.3 Seagen B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.4.4 Seagen B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.4.5 Seagen Key News
7.5 AbbVie
7.5.1 AbbVie Corporate Summary
7.5.2 AbbVie Business Overview
7.5.3 AbbVie B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.5.4 AbbVie B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.5.5 AbbVie Key News
7.6 Novartis
7.6.1 Novartis Corporate Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.6.4 Novartis B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.6.5 Novartis Key News
7.7 BioTherapeutics
7.7.1 BioTherapeutics Corporate Summary
7.7.2 BioTherapeutics Business Overview
7.7.3 BioTherapeutics B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.7.4 BioTherapeutics B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.7.5 BioTherapeutics Key News
7.8 Celgene
7.8.1 Celgene Corporate Summary
7.8.2 Celgene Business Overview
7.8.3 Celgene B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.8.4 Celgene B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.8.5 Celgene Key News
7.9 Bluebird Bio
7.9.1 Bluebird Bio Corporate Summary
7.9.2 Bluebird Bio Business Overview
7.9.3 Bluebird Bio B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.9.4 Bluebird Bio B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.9.5 Bluebird Bio Key News
7.10 Bristol Mayer Squibb
7.10.1 Bristol Mayer Squibb Corporate Summary
7.10.2 Bristol Mayer Squibb Business Overview
7.10.3 Bristol Mayer Squibb B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.10.4 Bristol Mayer Squibb B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.10.5 Bristol Mayer Squibb Key News
7.11 Carsgen Therapeutics
7.11.1 Carsgen Therapeutics Corporate Summary
7.11.2 Carsgen Therapeutics Business Overview
7.11.3 Carsgen Therapeutics B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.11.4 Carsgen Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.11.5 Carsgen Therapeutics Key News
7.12 Juno Therapeutics
7.12.1 Juno Therapeutics Corporate Summary
7.12.2 Juno Therapeutics Business Overview
7.12.3 Juno Therapeutics B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.12.4 Juno Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.12.5 Juno Therapeutics Key News
7.13 Cogent Bioscience
7.13.1 Cogent Bioscience Corporate Summary
7.13.2 Cogent Bioscience Business Overview
7.13.3 Cogent Bioscience B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.13.4 Cogent Bioscience B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.13.5 Cogent Bioscience Key News
7.14 CRISPR Therapeutics
7.14.1 CRISPR Therapeutics Corporate Summary
7.14.2 CRISPR Therapeutics Business Overview
7.14.3 CRISPR Therapeutics B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.14.4 CRISPR Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.14.5 CRISPR Therapeutics Key News
7.15 Allogene Therapeutics
7.15.1 Allogene Therapeutics Corporate Summary
7.15.2 Allogene Therapeutics Business Overview
7.15.3 Allogene Therapeutics B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.15.4 Allogene Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.15.5 Allogene Therapeutics Key News
7.16 Harpoon Therapeutics
7.16.1 Harpoon Therapeutics Corporate Summary
7.16.2 Harpoon Therapeutics Business Overview
7.16.3 Harpoon Therapeutics B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.16.4 Harpoon Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.16.5 Harpoon Therapeutics Key News
7.17 Poseida Therapeutics
7.17.1 Poseida Therapeutics Corporate Summary
7.17.2 Poseida Therapeutics Business Overview
7.17.3 Poseida Therapeutics B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.17.4 Poseida Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.17.5 Poseida Therapeutics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. B Cell Maturation Antigen Targeted Therapy Market Opportunities & Trends in Global Market
Table 2. B Cell Maturation Antigen Targeted Therapy Market Drivers in Global Market
Table 3. B Cell Maturation Antigen Targeted Therapy Market Restraints in Global Market
Table 4. Key Players of B Cell Maturation Antigen Targeted Therapy in Global Market
Table 5. Top B Cell Maturation Antigen Targeted Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global B Cell Maturation Antigen Targeted Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global B Cell Maturation Antigen Targeted Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies B Cell Maturation Antigen Targeted Therapy Product Type
Table 9. List of Global Tier 1 B Cell Maturation Antigen Targeted Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 B Cell Maturation Antigen Targeted Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Treatment Method ? Global B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2022 & 2030
Table 12. By Treatment Method - B Cell Maturation Antigen Targeted Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Treatment Method - B Cell Maturation Antigen Targeted Therapy Revenue in Global (US$, Mn), 2023-2030
Table 14. By Application ? Global B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - B Cell Maturation Antigen Targeted Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - B Cell Maturation Antigen Targeted Therapy Revenue in Global (US$, Mn), 2023-2030
Table 17. By Region ? Global B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn), 2023-2030
Table 20. By Country - North America B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2023-2030
Table 22. By Country - Europe B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2023-2030
Table 24. By Region - Asia B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2023-2030
Table 26. By Country - South America B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2023-2030
Table 28. By Country - Middle East & Africa B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2023-2030
Table 30. GlaxoSmithKline Corporate Summary
Table 31. GlaxoSmithKline B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 32. GlaxoSmithKline B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn), (2018-2023)
Table 33. Johnson & Johnson Corporate Summary
Table 34. Johnson & Johnson B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 35. Johnson & Johnson B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn), (2018-2023)
Table 36. Amgen Corporate Summary
Table 37. Amgen B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 38. Amgen B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn), (2018-2023)
Table 39. Seagen Corporate Summary
Table 40. Seagen B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 41. Seagen B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn), (2018-2023)
Table 42. AbbVie Corporate Summary
Table 43. AbbVie B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 44. AbbVie B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn), (2018-2023)
Table 45. Novartis Corporate Summary
Table 46. Novartis B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 47. Novartis B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn), (2018-2023)
Table 48. BioTherapeutics Corporate Summary
Table 49. BioTherapeutics B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 50. BioTherapeutics B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn), (2018-2023)
Table 51. Celgene Corporate Summary
Table 52. Celgene B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 53. Celgene B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn), (2018-2023)
Table 54. Bluebird Bio Corporate Summary
Table 55. Bluebird Bio B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 56. Bluebird Bio B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn), (2018-2023)
Table 57. Bristol Mayer Squibb Corporate Summary
Table 58. Bristol Mayer Squibb B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 59. Bristol Mayer Squibb B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn), (2018-2023)
Table 60. Carsgen Therapeutics Corporate Summary
Table 61. Carsgen Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 62. Carsgen Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn), (2018-2023)
Table 63. Juno Therapeutics Corporate Summary
Table 64. Juno Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 65. Juno Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn), (2018-2023)
Table 66. Cogent Bioscience Corporate Summary
Table 67. Cogent Bioscience B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 68. Cogent Bioscience B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn), (2018-2023)
Table 69. CRISPR Therapeutics Corporate Summary
Table 70. CRISPR Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 71. CRISPR Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn), (2018-2023)
Table 72. Allogene Therapeutics Corporate Summary
Table 73. Allogene Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 74. Allogene Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn), (2018-2023)
Table 75. Harpoon Therapeutics Corporate Summary
Table 76. Harpoon Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 77. Harpoon Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn), (2018-2023)
Table 78. Poseida Therapeutics Corporate Summary
Table 79. Poseida Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 80. Poseida Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. B Cell Maturation Antigen Targeted Therapy Segment by Treatment Method in 2022
Figure 2. B Cell Maturation Antigen Targeted Therapy Segment by Application in 2022
Figure 3. Global B Cell Maturation Antigen Targeted Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global B Cell Maturation Antigen Targeted Therapy Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global B Cell Maturation Antigen Targeted Therapy Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by B Cell Maturation Antigen Targeted Therapy Revenue in 2022
Figure 8. By Treatment Method - Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2018-2030
Figure 9. By Application - Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2018-2030
Figure 10. By Region - Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2018-2030
Figure 11. By Country - North America B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2018-2030
Figure 12. US B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 13. Canada B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 14. Mexico B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 15. By Country - Europe B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2018-2030
Figure 16. Germany B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 17. France B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 18. U.K. B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 19. Italy B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 20. Russia B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 21. Nordic Countries B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 22. Benelux B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 23. By Region - Asia B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2018-2030
Figure 24. China B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 25. Japan B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 26. South Korea B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 27. Southeast Asia B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 28. India B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 29. By Country - South America B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2018-2030
Figure 30. Brazil B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 31. Argentina B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 32. By Country - Middle East & Africa B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2018-2030
Figure 33. Turkey B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 34. Israel B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 35. Saudi Arabia B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 36. UAE B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2030
Figure 37. GlaxoSmithKline B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. Johnson & Johnson B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. Amgen B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. Seagen B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. AbbVie B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novartis B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. BioTherapeutics B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Celgene B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Bluebird Bio B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Bristol Mayer Squibb B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Carsgen Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Juno Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Cogent Bioscience B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. CRISPR Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Allogene Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Harpoon Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Poseida Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
